World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
70
Citations
20139
World Ranking
2497
National Ranking
47

Per Odin publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Per Odin sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 297 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Per Odin D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Per Odin sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 70 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Per Odin is affiliated with Lund University in Sweden and has contributed extensively to the field of medicine, with a strong emphasis on neurology. Their research encompasses a range of subfields including neurology, epidemiology, economics and econometrics, cognitive neuroscience, and cellular and molecular neuroscience. The primary focus lies in Parkinson's disease mechanisms and treatments, with additional attention to neurological disorders and treatments, botulinum toxin and related neurological disorders, restless legs syndrome research, autism spectrum disorder research, health systems, economic evaluations, quality of life, and balance, gait, and falls prevention.

Among the recent publications associated with Per Odin, notable papers include:

  • "Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals" (2023), published in Movement Disorders
  • "Management of Advanced Therapies in Parkinson's Disease Patients in Times of Humanitarian Crisis: The COVID-19 Experience" (2020), published in Movement Disorders Clinical Practice
  • "The Non-Motor Symptoms Scale in Parkinson's disease: Validation and use" (2020), published in Acta Neurologica Scandinavica
  • "The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review" (2021), published in Advances in Therapy
  • "Parkinson's Disease and Post-COVID-19 Syndrome: The Parkinson's Long-COVID Spectrum" (2021), published in Movement Disorders

Per Odin frequently collaborates with a group of co-authors, including:

  • К. Ray Chaudhuri
  • Angelo Antonini
  • Anette Schrag
  • Alexander Storch
  • Kristina Rosqvist

Their work has appeared regularly in several publication venues, with the most frequent being:

  • Movement Disorders Clinical Practice
  • Acta Neurologica Scandinavica
  • Journal of Parkinson's Disease
  • Movement Disorders
  • Parkinsonism & Related Disorders

Best Publications

  • The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

    Kallol Ray Chaudhuri;Pablo Martinez-Martin;Richard G. Brown;Kapil Sethi

  • Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study.

    C Warren Olanow;Karl Kieburtz;Per Odin;Alberto J Espay

  • Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients

    Pablo Martinez-Martin;Anthony H.V. Schapira;Fabrizio Stocchi;Kapil Sethi

  • Evidence for long‐term survival and function of dopaminergic grafts in progressive Parkinson's disease

    O Lindvall;Guy Sawle;H Widner;J C Rothwell

  • Parkinson's disease: The non-motor issues

    K. Ray Chaudhuri;Per Odin;Angelo Antonini;Pablo Martinez-Martin

  • The Nondeclaration of Nonmotor Symptoms of Parkinson's Disease to Health Care Professionals: An International Study Using the Nonmotor Symptoms Questionnaire

    K. Ray Chaudhuri;Cristina Prieto-Jurcynska;Yogini Naidu;Tanya Mitra

  • Short‐ and long‐term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

    Gregor K. Wenning;Per Odin;Paul Morrish;Stig Rehncrona

  • Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

    Joaquim J Ferreira;R. Katzenschlager;B. R. Bloem;U. Bonuccelli

  • Transplantation of fetal dopamine neurons in Parkinson's disease: one-year clinical and neurophysiological observations in two patients with putaminal implants

    O Lindvall;H Widner;S Rehncrona;Patrik Brundin

  • Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications.

    Alexander Storch;Christine B Schneider;Martin Wolz;Yannic Stürwald

  • Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease

    Patrik Brundin;O Pogarell;Peter Hagell;P Piccini

  • Gender-related differences in the burden of non-motor symptoms in Parkinson's disease.

    Pablo Martinez-Martin;Cristian Falup Pecurariu;Per Odin;Jacobus J. van Hilten

  • Intrajejunal Levodopa Infusion in Parkinson's Disease: A Pilot Multicenter Study of Effects on Nonmotor Symptoms and Quality of Life

    Holger Honig;Angelo Antonini;Pablo Martinez-Martin;Ian Forgacs

  • Levodopa Dose Equivalency in Parkinson's Disease: Updated Systematic Review and Proposals

    Unknown

  • Sequential bilateral transplantation in Parkinson's disease: effects of the second graft.

    Peter Hagell;A Schrag;P Piccini;M Jahanshahi

  • EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

    Pablo Martinez-Martin;Prashanth Reddy;Regina Katzenschlager;Angelo Antonini

  • King's Parkinson's disease pain scale, the first scale for pain in PD: An international validation.

    K. Ray Chaudhuri;Alexandra Rizos;C. Trenkwalder;O. Rascol

  • Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease : a multi-country Delphi-panel approach

    Angelo Antonini;A. Jon Stoessl;Leah S. Kleinman;Anne M. Skalicky

  • Subcutaneous apomorphine in late stage Parkinson’s disease: a long term follow up

    Katja Pietz;Peter Hagell;Per Odin

  • Levodopa-carbidopa intestinal gel in advanced Parkinson's disease: final 12-month, open-label results.

    Hubert H. Fernandez;David G. Standaert;Robert A. Hauser;Anthony E. Lang

  • Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program.

    Per Odin;K. Ray Chaudhuri;J T. Slevin;Jens Volkmann

  • Efficacy of rotigotine for treatment of moderate-to-severe restless legs syndrome: a randomised, double-blind, placebo-controlled trial

    Claudia Trenkwalder;Heike Beneš;Werner Poewe;Wolfgang H Oertel

  • The challenge of non-motor symptoms in Parkinson's disease.

    K. Ray Chaudhuri;Per Odin

  • Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review

    Jens Volkmann;Alberto Albanese;Angelo Antonini;K. Ray Chaudhuri

Frequent Co-Authors

Angelo Antonini
Angelo Antonini University of Padua
K. Ray Chaudhuri
K. Ray Chaudhuri King's College London
Pablo Martinez-Martin
Pablo Martinez-Martin Instituto de Salud Carlos III
Olle Lindvall
Olle Lindvall Lund University
Fabrizio Stocchi
Fabrizio Stocchi San Raffaele University of Rome
Håkan Widner
Håkan Widner Lund University
Hubert H. Fernandez
Hubert H. Fernandez Cleveland Clinic
Claudia Trenkwalder
Claudia Trenkwalder University of Göttingen
Kapil D. Sethi
Kapil D. Sethi Augusta University
Anthony H.V. Schapira
Anthony H.V. Schapira University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience can open doors to diverse online degree options and career paths in psychology, counseling, and social work. For those interested in foundational knowledge, a bachelor of psychology online offers an affordable and flexible entry point. This degree provides core skills and prepares graduates for a wide range of roles or further study.

Many careers supporting mental health and wellness now require advanced degrees. Aspiring clinical practitioners may consider msw online programs, which are popular for those who want to pursue social work with a neuroscience or psychology background. Alternatively, those seeking to deepen clinical skills can explore online psy d programs that focus on applied practice in psychology.

If you’re drawn to relationship and family counseling, best online mft programs train students to become licensed marriage and family therapists. Each pathway allows neuroscience students to specialize, advance their careers, and impact the growing field of mental health.

Best Scientists Citing Per Odin

Trending Scientists

Recently Published Articles